While more than half of employers that currently cover GLP-1s said they expected it would pay off in the long run in terms of overall health improvements, few reported seeing any evidence of that happening, contributing to long-term uncertainty
Research shows that it might improve peripheral nerve damage, prevent cardiovascular diseases and alleviate dementia
This initial week is a crucial adjustment period where your central nervous system and digestive tract learn to communicate under the influence of the medication
Those that do cover them typically do so through their medical benefit, offering GLP-1s through a rebate negotiated by their pharmacy benefit manager (PBM), she said
If its above 600 pg/mL, functional deficiency is unlikely (though not impossible in rare cases)
Rodrigues B, Xiang H & Mcneill HJ (1988): Effect of L-carnitine traerment on lipid metabolism and performance in chronically diabetic rats